Douglas C. Saffran

4.1k citations
33 papers · 3.2k indexed · 2 hit papers · h-index 17
Topics
Chronic Lymphocytic Leukemia Research (8 papers)Immunodeficiency and Autoimmune Disorders (8 papers)Prostate Cancer Treatment and Research (5 papers)

In The Last Decade

Douglas C. Saffran

33 papers receiving 3.1k citations

Hit Papers

Deficient expression of a B cell cytoplasmic tyrosine kin...1993202620042015199319932505007501000

Peers

Douglas C. Saffran
Comparison fields: 5 of 93
  • Immunology 1.9k
  • Genetics 1.1k
  • Molecular Biology 890
  • Hematology 604
  • Oncology 509
Replace Anne B. Satterthwaite with:
Anne B. Satterthwaite United States
Hilmar Quentmeier Germany
François Sigaux France
Serge Fichelson France
Yann Lécluse France
Mary L. Bath Australia
Meike Burger Germany
Che‐Leung Law United States
Kevin T. McDonagh United States
Sylvie Freeman United Kingdom
Douglas C. Saffran relative to Anne B. Satterthwaite United States Anne B. Satterthwaite's profile →
Citations per field
00.5×1.5×
Anne B. Satterthwaite · 1×
Citations per year

Countries citing papers authored by Douglas C. Saffran

Since Specialization
Citations

This map shows the geographic impact of Douglas C. Saffran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas C. Saffran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas C. Saffran more than expected).

Fields of papers citing papers by Douglas C. Saffran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas C. Saffran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas C. Saffran. The network helps show where Douglas C. Saffran may publish in the future.

Co-authorship network of co-authors of Douglas C. Saffran

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas C. Saffran. A scholar is included among the top collaborators of Douglas C. Saffran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas C. Saffran. Douglas C. Saffran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 2
4 44
5 2
6 19
7 5
8 1
9
Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.
199
10 23
11 37
12 6
13 217
14 72
15 98
16
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiabreakdown →
1053
17 50
18 10
19 4
20 10

About Douglas C. Saffran

Douglas C. Saffran is a scholar working on Genetics, Immunology and Hematology, having authored 33 papers that have together received 3.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Immunodeficiency and Autoimmune Disorders (8 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Genetics (1.1k citations), Immunology (1.9k citations) and Hematology (604 citations). Douglas C. Saffran has collaborated with scholars based in United States, Canada and Finland. Frequent co-authors include Owen N. Witte, David J. Rawlings, Satoshi Tsukada, Daniel Afar, Ornella Parolini, Mary Ellen Conley, Ivana Klisak, Shirley G. Quan, R.Cutler Allen and T. Mohandas. Their work appears in journals such as Science, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026